BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2530 related articles for article (PubMed ID: 30417375)

  • 1. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
    Clara JA; Monge C; Yang Y; Takebe N
    Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
    Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
    Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
    Yan Y; Zuo X; Wei D
    Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
    Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
    Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancer stem cell pathways for cancer therapy.
    Yang L; Shi P; Zhao G; Xu J; Peng W; Zhang J; Zhang G; Wang X; Dong Z; Chen F; Cui H
    Signal Transduct Target Ther; 2020 Feb; 5(1):8. PubMed ID: 32296030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
    Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
    Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
    Katoh M
    Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
    Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
    Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
    Oshimori N
    Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy.
    Rouzbahani E; Majidpoor J; Najafi S; Mortezaee K
    Biomed Pharmacother; 2022 Dec; 156():113906. PubMed ID: 36306594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
    Najafi M; Mortezaee K; Ahadi R
    Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
    Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
    Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
    Zeng Z; Fu M; Hu Y; Wei Y; Wei X; Luo M
    Mol Cancer; 2023 Oct; 22(1):172. PubMed ID: 37853437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 127.